Cargando…
812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds
INTRODUCTION: In full-thickness (FT) wounds, autologous skin cell suspension (ASCS) is used in combination with widely meshed split-thickness skin grafts (mSTSGs) to obtain definitive closure, reducing donor skin requirements compared to traditional autografting (AG) techniques. In the treatment of...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945930/ http://dx.doi.org/10.1093/jbcr/irac012.360 |
_version_ | 1784674071633461248 |
---|---|
author | Hickerson, William L Mangum, Lauren Bell, Cameron C Bush, Katie A |
author_facet | Hickerson, William L Mangum, Lauren Bell, Cameron C Bush, Katie A |
author_sort | Hickerson, William L |
collection | PubMed |
description | INTRODUCTION: In full-thickness (FT) wounds, autologous skin cell suspension (ASCS) is used in combination with widely meshed split-thickness skin grafts (mSTSGs) to obtain definitive closure, reducing donor skin requirements compared to traditional autografting (AG) techniques. In the treatment of these wounds, dermal matrices (DMs) are also often utilized to address various challenges including need for temporization, mitigation of contour defects, covering avascular structures, and modulation of scar formation. Varying DMs exist and are composed of different biologic and synthetic materials designed to address these clinical needs. The purpose of this study was to compare outcomes obtained in FT wounds using 3 different DMs coupled with ASCS+mSTSG in immediate or delayed AG procedures. METHODS: A FT excisional porcine wound model was used. DMs evaluated included a single-layer dermal matrix composed of bovine dermal collagen and elastin (Col/E), a bilayer construct composed of a bovine collagen-glycosaminoglycan with a silicone epidermal layer (Col/GAG), and a synthetic bilayer polyurethane DM (Poly/U). DMs were applied, managed, and grafted following manufacturer’s recommendations. AG included ASCS+mSTSG (1:80 expansion, 3:1 mesh). Wounds were evaluated for inflammation, infection, DM take, AG take, re-epithelialization, and contracture over 49 days post-excision. Additionally, biopsies were evaluated to further inform tissue generation and healing outcomes. RESULTS: Results related to healing outcomes are reported in the table below. Inflammation at wound margins was noted during acute phase of healing for all DMs and visual cues for infection were noted in 1 wound for Col/E, 3 wounds for Col/GAG causing partial loss of DM, and 1 wound for Poly/U. All signs of infection were resolved by day 14. CONCLUSIONS: ASCS+mSTSG can be used successfully over DMs composed of various materials in both immediate and delayed AG procedures. No difference was observed on percent AG take between the DMs, however the data suggest that time to definitive closure is impacted based on utilized DM and AG strategy, with potential implications on contracture. |
format | Online Article Text |
id | pubmed-8945930 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-89459302022-03-28 812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds Hickerson, William L Mangum, Lauren Bell, Cameron C Bush, Katie A J Burn Care Res Translational Sciences: Wounds & Scars 2 INTRODUCTION: In full-thickness (FT) wounds, autologous skin cell suspension (ASCS) is used in combination with widely meshed split-thickness skin grafts (mSTSGs) to obtain definitive closure, reducing donor skin requirements compared to traditional autografting (AG) techniques. In the treatment of these wounds, dermal matrices (DMs) are also often utilized to address various challenges including need for temporization, mitigation of contour defects, covering avascular structures, and modulation of scar formation. Varying DMs exist and are composed of different biologic and synthetic materials designed to address these clinical needs. The purpose of this study was to compare outcomes obtained in FT wounds using 3 different DMs coupled with ASCS+mSTSG in immediate or delayed AG procedures. METHODS: A FT excisional porcine wound model was used. DMs evaluated included a single-layer dermal matrix composed of bovine dermal collagen and elastin (Col/E), a bilayer construct composed of a bovine collagen-glycosaminoglycan with a silicone epidermal layer (Col/GAG), and a synthetic bilayer polyurethane DM (Poly/U). DMs were applied, managed, and grafted following manufacturer’s recommendations. AG included ASCS+mSTSG (1:80 expansion, 3:1 mesh). Wounds were evaluated for inflammation, infection, DM take, AG take, re-epithelialization, and contracture over 49 days post-excision. Additionally, biopsies were evaluated to further inform tissue generation and healing outcomes. RESULTS: Results related to healing outcomes are reported in the table below. Inflammation at wound margins was noted during acute phase of healing for all DMs and visual cues for infection were noted in 1 wound for Col/E, 3 wounds for Col/GAG causing partial loss of DM, and 1 wound for Poly/U. All signs of infection were resolved by day 14. CONCLUSIONS: ASCS+mSTSG can be used successfully over DMs composed of various materials in both immediate and delayed AG procedures. No difference was observed on percent AG take between the DMs, however the data suggest that time to definitive closure is impacted based on utilized DM and AG strategy, with potential implications on contracture. Oxford University Press 2022-03-23 /pmc/articles/PMC8945930/ http://dx.doi.org/10.1093/jbcr/irac012.360 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the American Burn Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Translational Sciences: Wounds & Scars 2 Hickerson, William L Mangum, Lauren Bell, Cameron C Bush, Katie A 812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds |
title | 812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds |
title_full | 812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds |
title_fullStr | 812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds |
title_full_unstemmed | 812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds |
title_short | 812 Evaluation of Dermal and Epidermal Replacement Strategies for the Treatment of Full-thickness Wounds |
title_sort | 812 evaluation of dermal and epidermal replacement strategies for the treatment of full-thickness wounds |
topic | Translational Sciences: Wounds & Scars 2 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945930/ http://dx.doi.org/10.1093/jbcr/irac012.360 |
work_keys_str_mv | AT hickersonwilliaml 812evaluationofdermalandepidermalreplacementstrategiesforthetreatmentoffullthicknesswounds AT mangumlauren 812evaluationofdermalandepidermalreplacementstrategiesforthetreatmentoffullthicknesswounds AT bellcameronc 812evaluationofdermalandepidermalreplacementstrategiesforthetreatmentoffullthicknesswounds AT bushkatiea 812evaluationofdermalandepidermalreplacementstrategiesforthetreatmentoffullthicknesswounds |